Jayagopal Ashwath 4
4 · Opus Genetics, Inc. · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-13+52,500→ 52,500 totalExercise: $0.93Exp: 2035-03-12→ Common Stock (52,500 underlying) - Award
Common Stock
2025-03-13+52,500→ 125,807 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.
- [F2]The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.